chr4-9450379-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001040448.3(DEFB131A):c.78T>A(p.Asn26Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000159 in 1,572,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001040448.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFB131A | NM_001040448.3 | c.78T>A | p.Asn26Lys | missense_variant | 2/2 | ENST00000334879.2 | NP_001035538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB131A | ENST00000334879.2 | c.78T>A | p.Asn26Lys | missense_variant | 2/2 | 1 | NM_001040448.3 | ENSP00000335538.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000133 AC: 3AN: 224976Hom.: 0 AF XY: 0.00000818 AC XY: 1AN XY: 122254
GnomAD4 exome AF: 0.00000493 AC: 7AN: 1420646Hom.: 0 Cov.: 31 AF XY: 0.00000285 AC XY: 2AN XY: 702886
GnomAD4 genome AF: 0.000118 AC: 18AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.78T>A (p.N26K) alteration is located in exon 2 (coding exon 2) of the DEFB131 gene. This alteration results from a T to A substitution at nucleotide position 78, causing the asparagine (N) at amino acid position 26 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at